Immunotherapy significantly increases the number of patients free from bowel cancer
Immunotherapy significantly increases the number of patients free from bowel cancer
Best practice in HRRm testing in patients with metastatic prostate cancer
ASCO 2024: Lung cancer roundup
Trial argues strongly for the development of 1st-line biomarker selected strategies in pancreatic ductal adenocarcinoma
ARV-766 well tolerated and shows promising clinical activity in metastatic castration-resistant prostate cancer
ASCO 2024: Highlights and analysis
ASCO 2024: Advances in NSCLC
ASCO 2024: Two studies report on isatuximab combos in transplant-ineligible patients with newly diagnosed multiple myeloma
Osimertinib success in locally advanced EGFR-mutated NSCLC
Manageable safety profile with early efficacy of Tec-DR in NDMM
Inavolisib, palbociclib, fulvestrant combo shows sustained benefit beyond disease progression in HER2‑negative metastatic breast cancer
Lutetium-177–PSMA-617 improves self-reported pain and HRQoL in taxane-naïve patients with PSMA-positive mCRPC